Wealthcare Advisory Partners LLC Has $364,000 Position in Colgate-Palmolive (NYSE:CL)

Wealthcare Advisory Partners LLC raised its stake in Colgate-Palmolive (NYSE:CL) by 4.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,009 shares of the company’s stock after acquiring an additional 162 shares during the quarter. Wealthcare Advisory Partners LLC’s holdings in Colgate-Palmolive were worth $364,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of CL. XTX Topco Ltd bought a new position in shares of Colgate-Palmolive in the 2nd quarter worth about $423,000. AE Wealth Management LLC increased its holdings in Colgate-Palmolive by 70.9% in the second quarter. AE Wealth Management LLC now owns 22,607 shares of the company’s stock worth $2,194,000 after purchasing an additional 9,382 shares in the last quarter. Sei Investments Co. lifted its stake in Colgate-Palmolive by 1.8% in the second quarter. Sei Investments Co. now owns 609,139 shares of the company’s stock valued at $59,111,000 after buying an additional 10,500 shares during the period. Summit Trail Advisors LLC boosted its holdings in shares of Colgate-Palmolive by 2.6% during the 2nd quarter. Summit Trail Advisors LLC now owns 5,490 shares of the company’s stock worth $533,000 after buying an additional 141 shares in the last quarter. Finally, Westwood Holdings Group Inc. grew its position in shares of Colgate-Palmolive by 35.8% during the 2nd quarter. Westwood Holdings Group Inc. now owns 4,362 shares of the company’s stock worth $423,000 after buying an additional 1,151 shares during the period. 80.41% of the stock is currently owned by institutional investors.

Insider Activity

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.37% of the company’s stock.

Colgate-Palmolive Trading Up 0.3 %

Shares of NYSE CL opened at $88.79 on Tuesday. Colgate-Palmolive has a 1-year low of $79.69 and a 1-year high of $109.30. The business has a fifty day moving average price of $92.20 and a 200 day moving average price of $97.76. The stock has a market capitalization of $72.55 billion, a P/E ratio of 25.44, a price-to-earnings-growth ratio of 3.01 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.25%. Colgate-Palmolive’s payout ratio is currently 57.31%.

Analyst Ratings Changes

A number of research firms have commented on CL. TD Cowen reduced their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, January 8th. Piper Sandler reduced their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. Stifel Nicolaus cut their price target on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a report on Friday. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Finally, JPMorgan Chase & Co. cut their target price on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a report on Thursday, January 16th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Colgate-Palmolive presently has an average rating of “Hold” and a consensus target price of $101.11.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.